plant-based
-
DATABASE (850)
-
ARTICLES (615)
Endeavor Catalyst is part of the global investment company Endeavor. Launched in 2012 and based in New York, it supports the equity funding efforts of Endeavour entrepreneurs with third party investors. Its portfolio investments had a total capital value of over US$100 million and it specializes in mid-stage investments across sectors and different countries, with significant investment in transportation startups to date. In 2020, it participated in the second €12m part of the €23m Series A round of EV charging hardware startup, Wallbox, with an undisclosed investment. Other recent investments in 2020 include in the US$40m Series D round of Egyptian healthtech Vezeeta and in the undisclosed seed round of Turkish fintech Figopara.
Endeavor Catalyst is part of the global investment company Endeavor. Launched in 2012 and based in New York, it supports the equity funding efforts of Endeavour entrepreneurs with third party investors. Its portfolio investments had a total capital value of over US$100 million and it specializes in mid-stage investments across sectors and different countries, with significant investment in transportation startups to date. In 2020, it participated in the second €12m part of the €23m Series A round of EV charging hardware startup, Wallbox, with an undisclosed investment. Other recent investments in 2020 include in the US$40m Series D round of Egyptian healthtech Vezeeta and in the undisclosed seed round of Turkish fintech Figopara.
Iberis Capital is a Portuguese investor established in 2017. Currently with 10 investments with more than €100m under management, it invests in both tech and non-tech startups and in real estate. Iberis was founded by ex-partner at Oxy Capital Luís Quaresma and João Henriques, ex-CFO of Vodafone Portugal. One of its prominent portfolio companies is Australian medtech LBT Innovations that seeks to automate healthcare processes and, to date, has the only US Food and Drug Administration-cleared instrument leveraging AI in clinical microbiology. Its most recent investment was a participation in a €32m Series C investment round in December 2020 for Portugal-based international online print store, 360imprimir.
Iberis Capital is a Portuguese investor established in 2017. Currently with 10 investments with more than €100m under management, it invests in both tech and non-tech startups and in real estate. Iberis was founded by ex-partner at Oxy Capital Luís Quaresma and João Henriques, ex-CFO of Vodafone Portugal. One of its prominent portfolio companies is Australian medtech LBT Innovations that seeks to automate healthcare processes and, to date, has the only US Food and Drug Administration-cleared instrument leveraging AI in clinical microbiology. Its most recent investment was a participation in a €32m Series C investment round in December 2020 for Portugal-based international online print store, 360imprimir.
Founded by Hillhouse Capital in February 2020, GL Ventures mainly invests in early-stage startups from diverse sectors like pharmaceutical, SaaS, internet-based consumption/technology and emerging consumer goods/services.The RMB/USD dual currency VC-arm of Hillhouse currently manages total funds worth RMB 10bn from limited partners including university endowments, sovereign wealth funds, pension funds, FOF and family offices. The VC has made nearly 200 investments in its first year of operations.
Founded by Hillhouse Capital in February 2020, GL Ventures mainly invests in early-stage startups from diverse sectors like pharmaceutical, SaaS, internet-based consumption/technology and emerging consumer goods/services.The RMB/USD dual currency VC-arm of Hillhouse currently manages total funds worth RMB 10bn from limited partners including university endowments, sovereign wealth funds, pension funds, FOF and family offices. The VC has made nearly 200 investments in its first year of operations.
Mercy Corps’ Social Venture Fund
Mercy Corps’ Social Venture Fund is a seed and early-stage social impact fund operated by not-for-profit humanitarian organization Mercy Corps. The US-based organization is increasingly moving into tech investments, with key interests in agtech and fintech solutions creating social impact. FinX, a platform designed to accelerate financial inclusion worldwide, was also launched recently. Distributed ledgers, digital assets, cryptocurrencies and other digital financial solutions will be deployed to alleviate poverty in local communities. The fund has invested in 16 companies at the seed stage. Investments in the February 2021 included a pre-seed round for Kenyan healthcare fintech platform ImaliPay. In December 2020, it joined a $5.3m seed round for Colombian remittance tech Valiu.
Mercy Corps’ Social Venture Fund is a seed and early-stage social impact fund operated by not-for-profit humanitarian organization Mercy Corps. The US-based organization is increasingly moving into tech investments, with key interests in agtech and fintech solutions creating social impact. FinX, a platform designed to accelerate financial inclusion worldwide, was also launched recently. Distributed ledgers, digital assets, cryptocurrencies and other digital financial solutions will be deployed to alleviate poverty in local communities. The fund has invested in 16 companies at the seed stage. Investments in the February 2021 included a pre-seed round for Kenyan healthcare fintech platform ImaliPay. In December 2020, it joined a $5.3m seed round for Colombian remittance tech Valiu.
DSM Venturing is the investment arm of major Dutch biotech company DSM that has been investing in startups since 2006. The company currently has 36 startups in its portfolio across geographies and has managed three exits to date. It typically invests between €100,000 and €5m, with a lifetime investment varying from €1m–20m and usually requires board membership alongside investment. It has offices in the Netherlands and the US, both on the east and west coast. Its recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the same month, in the $8m Series A round of British anti-pollution biotech Deep Branch Biotechnology.
DSM Venturing is the investment arm of major Dutch biotech company DSM that has been investing in startups since 2006. The company currently has 36 startups in its portfolio across geographies and has managed three exits to date. It typically invests between €100,000 and €5m, with a lifetime investment varying from €1m–20m and usually requires board membership alongside investment. It has offices in the Netherlands and the US, both on the east and west coast. Its recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the same month, in the $8m Series A round of British anti-pollution biotech Deep Branch Biotechnology.
Albert Wenger is a managing partner at New York-based Union Square Ventures. He is also an angel investor with disclosed investments in 25 startups, many in the area of sustainability. His most recent investments have been in the April 2021 $6.2m seed round of Finnish carbon sequestration startup Carbon Culture and in the $9.5m Series A round of French web browser innovation company Beam.
Albert Wenger is a managing partner at New York-based Union Square Ventures. He is also an angel investor with disclosed investments in 25 startups, many in the area of sustainability. His most recent investments have been in the April 2021 $6.2m seed round of Finnish carbon sequestration startup Carbon Culture and in the $9.5m Series A round of French web browser innovation company Beam.
Vesalius Biocapital III is a €70 million fund that invests in medtech, e-health initiatives and drug development in Europe. It was launched in 2017 by Luxembourg-based Vesalius Biocapital, a life sciences venture capital firm founded in 2007. Preceding Vesalius Biocapital III were Vesalius Biocapital I, with €76 million under management and Vesalius Biocapital II, which has €78 million invested; both funds have 11 portfolio companies each.Its recent investments include in Portuguese home physiotherapy tech solution SWORD Health's 2021 $25m Series B and in the 2020 $9m second phase of its Series A round as well as in the 2020 €22m Series B round of German biotech Topas Therapeutics.
Vesalius Biocapital III is a €70 million fund that invests in medtech, e-health initiatives and drug development in Europe. It was launched in 2017 by Luxembourg-based Vesalius Biocapital, a life sciences venture capital firm founded in 2007. Preceding Vesalius Biocapital III were Vesalius Biocapital I, with €76 million under management and Vesalius Biocapital II, which has €78 million invested; both funds have 11 portfolio companies each.Its recent investments include in Portuguese home physiotherapy tech solution SWORD Health's 2021 $25m Series B and in the 2020 $9m second phase of its Series A round as well as in the 2020 €22m Series B round of German biotech Topas Therapeutics.
Torch Capital is a venture capital firm based in New York, primarily investing in seed and Series A rounds with check sizes ranging from $500,000 to $3m. Founded in 2018, the firm raised its first fund of $60m in June 2019, making 15 investments within its first year of operations. Torch Capital has made a total of 46 investments and 10 exits to date. Two investees, Compass and Digital Ocean, are now public-listed companies.Founder and managing partner Jonathan Keidan previously worked for McKinsey and Company and for General Electric CEO Jack Welsh. Keidan is also the co-founder of digital media publication InsideHook.
Torch Capital is a venture capital firm based in New York, primarily investing in seed and Series A rounds with check sizes ranging from $500,000 to $3m. Founded in 2018, the firm raised its first fund of $60m in June 2019, making 15 investments within its first year of operations. Torch Capital has made a total of 46 investments and 10 exits to date. Two investees, Compass and Digital Ocean, are now public-listed companies.Founder and managing partner Jonathan Keidan previously worked for McKinsey and Company and for General Electric CEO Jack Welsh. Keidan is also the co-founder of digital media publication InsideHook.
Founded in 2004, Zurich-based Alpha Associates is a spin-off from Swiss Life Private Equity Partners. The independent fund manager and advisor specializes in private equity, private debt and infrastructure investments, offering investment services to institutional and private wealth clients.Besides offering a range of private market funds of funds, Alpha also manages Private Equity Holding Ltd with a diversified portfolio of investments in six public-listed companies. Recent direct co-investments include participation in the $54m Series B round of Austrian marketplace Refurbed in August 2021.
Founded in 2004, Zurich-based Alpha Associates is a spin-off from Swiss Life Private Equity Partners. The independent fund manager and advisor specializes in private equity, private debt and infrastructure investments, offering investment services to institutional and private wealth clients.Besides offering a range of private market funds of funds, Alpha also manages Private Equity Holding Ltd with a diversified portfolio of investments in six public-listed companies. Recent direct co-investments include participation in the $54m Series B round of Austrian marketplace Refurbed in August 2021.
Rubio Impact Ventures (formerly Social Impact Ventures)
Founded in Amsterdam in 2014, Rubio Impact Ventures was formerly known as Social Impact Ventures. The VC currently invests in sustainability-focused startups that are predominantly based in the Netherlands and north-western Europe. It currently has 27 portfolio companies including fair coffee brand Wakuli and cultured meat pioneer Masa Meat. The “Rubicon crossing” VC has just raised €110m for its second impact fund, Rubio Fund 2, in October 2021.Recent investments include participation in the $43m Series B round of food-sharing app OLIO in September 2021 and the €3.6m seed round in July 2021 for Portuguese Arborea that uses micro-organisms in biotech for foodtech applications.
Founded in Amsterdam in 2014, Rubio Impact Ventures was formerly known as Social Impact Ventures. The VC currently invests in sustainability-focused startups that are predominantly based in the Netherlands and north-western Europe. It currently has 27 portfolio companies including fair coffee brand Wakuli and cultured meat pioneer Masa Meat. The “Rubicon crossing” VC has just raised €110m for its second impact fund, Rubio Fund 2, in October 2021.Recent investments include participation in the $43m Series B round of food-sharing app OLIO in September 2021 and the €3.6m seed round in July 2021 for Portuguese Arborea that uses micro-organisms in biotech for foodtech applications.
China’s first and largest enterprise-level trading desk, Chinapex provides a real-time AI-powered customer data platform for marketing, personalization and analytics.
China’s first and largest enterprise-level trading desk, Chinapex provides a real-time AI-powered customer data platform for marketing, personalization and analytics.
Periksa.id’s web-based data management platform has a comprehensive suite of features to help improve profitability and productivity of Indonesia’s hospitals and clinics.
Periksa.id’s web-based data management platform has a comprehensive suite of features to help improve profitability and productivity of Indonesia’s hospitals and clinics.
East Ventures-backed microbiome personalized skincare firm is also known for helping produce Indonesia's first Covid-19 test kit, as part of state R&D collaboration.
East Ventures-backed microbiome personalized skincare firm is also known for helping produce Indonesia's first Covid-19 test kit, as part of state R&D collaboration.
Squirrel AI's adaptive learning system lets students study at their own pace while targeting their weaknesses, achieving 5–10 times greater efficacy than conventional schools.
Squirrel AI's adaptive learning system lets students study at their own pace while targeting their weaknesses, achieving 5–10 times greater efficacy than conventional schools.
Based in Madrid, K Fund is a VC firm founded in July 2016 by Ian Noel and Iñaki Arrola, focusing on seed and early-stage investments in digital technology startups. It has to date raised one fund of €50m. As of 1Q 2020, K Fund had invested in 25 companies, with its most recent investments including HR platform Factorial's €15m Series A round and in open source platform Frontity's €1m seed round.Noel represents Bonsai VC while Arrola is a serial entrepreneur (Coches.com and Vitamina K). A third co-founder is Carina Szpilka from ING Direct. Other team members include Ignacio Larrú (IE Business School), Pablo Ventura (JME Ventures) and technology journalist Jaime Novoa (Novobrief, Tech.eu). K Fund’s other investors include public institutions such as EIF and private investors.
Based in Madrid, K Fund is a VC firm founded in July 2016 by Ian Noel and Iñaki Arrola, focusing on seed and early-stage investments in digital technology startups. It has to date raised one fund of €50m. As of 1Q 2020, K Fund had invested in 25 companies, with its most recent investments including HR platform Factorial's €15m Series A round and in open source platform Frontity's €1m seed round.Noel represents Bonsai VC while Arrola is a serial entrepreneur (Coches.com and Vitamina K). A third co-founder is Carina Szpilka from ING Direct. Other team members include Ignacio Larrú (IE Business School), Pablo Ventura (JME Ventures) and technology journalist Jaime Novoa (Novobrief, Tech.eu). K Fund’s other investors include public institutions such as EIF and private investors.
Mycorena: Fungi-based vegan protein challenging traditional plant-based ingredients
Award-winning Swedish biotech startup is scaling production of mycoprotein to become a key player in the emerging market for functional proteins
Grain Meat: Focusing on whole cut plant-based meat
With its proprietary fiber weaving technique and specially-designed machinery, Wuxi-based Grain Meat aims to replicate the texture and even the grain of real meat
Zhenmeat: Offering a modern plant-based meat alternative in China
The Chinese startup is providing a product adapted for Chinese tastes in an emerging market.
Plant-based eggs (Part II): The foodtech startups to watch
Here’s a shortlist of the foodtech startups to watch in the global vegan egg market
New Food Invest: Plant-based cheese, the next investment boom?
With alt-protein startups experiencing a global funding boom, industry experts and investors share their views about emerging trends in diverse food sectors
Plant-based meat faces backlash in China despite gaining traction
An innocuous video clip sparked debate on social media over plant-based meat, with suspicion about its nutritional value, cost-effectiveness and even the motives of foreign companies
Yali Bio: Recreating a juicy steak in plant-based alternatives
Founded by the former head of Impossible Foods’ pilot plant, this Bay Area genomics and foodtech startup is one of the first to engineer a better fat for plant-based meat
New Food Invest: Building a plant-based business in the US
With plant-based startups experiencing exponential growth but facing increasingly intense competition, experts consider the opportunities and barriers in the sector
NotCo: Will this Bezos-backed plant-based foodtech be Chile's first unicorn?
Armed with $85m Series C funding, NotCo has expanded to the US, competing head-on with popular US alt-protein brands for a foothold in the multibillion-dollar vegan market
Plant-based eggs: The next big thing in the alternative protein market
Plant-based eggs may be the fastest growing segment in plant-based foods, but hacking the formula for a perfect egg substitute is proving a hurdle. Are alt-protein startups up for the challenge?
Indonesia's Green Rebel Foods to take its Asian-inspired plant-based meat regional
F&B veteran duo behind the Burgreens spinoff plans Series A fundraising by end-2021 for manufacturing and regional expansion
In a nascent market, one-year-old Starfield has brought its offerings to around 3,000 F&B outlets and generated RMB 10m in revenue
Do plant-based meat alternatives stand a chance in China, the world's largest meat consumer?
Major food brands and foodtech startups are trying to build their following in a nascent market forecast to grow to nearly $12bn worth by 2023
Dao Foods: Grooming and betting on China's rising alternative protein startups
How can businesses involve Chinese consumers in the environmental cause, even if it isn’t a priority for them? For that, the impact investor-incubator Dao Foods has got its philosophy-led strategy figured out
SWITCH Singapore: Alternative protein sure to take off in Asia, with Singapore as innovation hotbed
In an in-depth discussion, food industry experts say products made with alternative protein in hybrid forms could offer the fastest route to commercialization
Sorry, we couldn’t find any matches for “plant-based”.
POPULAR DATABASE
